Glycopeptide resistance in coagulase-negative staphylococci

Coagulase-negative staphylococci (CNS) were the first organisms in which acquired glycopeptide resistance was recognized. Ever since the early reports, it has been apparent that resistance to teicoplanin is more common than that to vancomycin and that resistance occurs mostly in species such as Stap...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical microbiology & infectious diseases 2000-06, Vol.19 (6), p.403-417
Hauptverfasser:	BIAVASCO, F, VIGNAROLI, C, VARALDO, P. E
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibacterial agents Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Bacterial infections Biological and medical sciences Clinical medicine Coagulase - metabolism Drug Resistance, Microbial glycopeptide antibiotics Gram-positive bacteria Humans Infections Laboratories Medical sciences Microbial Sensitivity Tests Pathogens Pharmacology. Drug treatments Population studies Staphylococcal Infections - drug therapy Staphylococcal Infections - microbiology Staphylococcus - drug effects Staphylococcus - enzymology Staphylococcus - genetics Staphylococcus epidermidis Staphylococcus haemolyticus Teicoplanin - pharmacology Teicoplanin - therapeutic use Toxicity Vancomycin - pharmacology Vancomycin - therapeutic use Vancomycin Resistance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!